Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of phosphatidylinositol-3-kinase catalytic subunit (PIK3CA) and epidermal growth factor receptor (EGFR) gene mutations in pancreaticobiliary adenocarcinoma.

1 Mar 2013

Abstract excerpt

BACKGROUND: Phosphatidylinositol-3-kinase (PI3K) activation involves the epidermal growth factor receptor (EGFR) and plays an important role in cell survival signaling in pancreaticobiliary cancer. EGFR gene mutations have been correlated with clinical response to EGFR inhibitors in patients with advanced non-small cell lung cancer. This study examined the prevalence of PIK3CA and EGFR mutations in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to Lung Cancer Treatments and Mutations
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23450128
DOI: 10.3978/j.issn.2078-6891.2012.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of phosphatidylinositol-3-kinase catalytic subunit (PIK3CA) and epidermal growth factor receptor (EGFR) gene mutations in pancreaticobiliary adenocarcinoma.PMID 23450128Read ↗

Epidermal growth factor receptor (EGFR) is highly conserved in pancreatic cancer.Semantic proximity Read ↗

Clinical relevance of epidermal growth factor receptor (EGFR) alterations in human pancreatic tumors.Semantic proximity Read ↗

Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma.Semantic proximity Read ↗

EGFR and KRAS mutational analysis and their correlation to survival in pancreatic and periampullary cancer.Semantic proximity Read ↗

Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas.Semantic proximity Read ↗

Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling.Semantic proximity Read ↗

Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes.Semantic proximity Read ↗

Loss of heterozygosity predicts poor survival after resection of pancreatic adenocarcinoma.Semantic proximity Read ↗

EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104.Semantic proximity Read ↗

Frequent mutation of the PIK3CA gene in ovarian and breast cancers.Semantic proximity Read ↗

PIK3CA Mutational Analysis in Formalin-Fixed, Paraffin-Embedded Archival Tissues of Urothelial Carcinoma of Urinary BladderSemantic proximity Read ↗

Diagnostic accuracy of K-ras mutation for pancreatic carcinoma: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.